236 Users Online
A Detailed Analysis of the Central Venous Catheter Market Based on the Constantly Rising Prevalence of Chronic Diseases Worldwide
The global central venous catheter market is forecast to expand at a CAGR of 5% and thereby increase from a value of US$3.2 Bn in 2023, to US$4.5 Bn by the end of 2030.
Central Venous Catheter Market Size (2023E)
Projected Market Value (2030F)
Global Market Growth Rate (CAGR 2023 to 2030)
Historical Market Growth Rate (CAGR 2018 to 2022)
A central venous catheter (CVC) is a medical apparatus that is inserted into a sizable vein, usually located in the groin, torso, or neck, to enable the direct and effective circulation of substances, fluids, or nutrients into the bloodstream. Catheters are of paramount importance in the provision of patient care as they facilitate the administration of treatments, the monitoring of blood parameters, and the maintenance of intravenous access for a prolonged period. Variable in design and purpose, CVCs include peripherally inserted, tunneled, and non-tunneled catheters, which serve a variety of medical purposes. Conspicuous in oncology, critical care, and long-term therapies, CVCs are utilized frequently, which demonstrates their adaptability and importance in contemporary healthcare systems.
The worldwide market for central venous catheters is expanding significantly, propelled by several critical factors. To begin with, the escalating prevalence of chronic ailments, such as cardiovascular disorders and cancer, mandates extended medical interventions, consequently amplifying the need for CVCs. Additionally, the expanding elderly population, which frequently necessitates advanced medical interventions, contributes to market expansion. Catheter design technological advancements that enhance user-friendliness and safety serve to further propel market growth. Further contributing to the market's ascent are the rising incidence of infectious diseases and the expanding number of surgical procedures that necessitate protracted and accurate intravenous treatment.
Increasing Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is the primary factor propelling the exponential growth of the global central venous catheter market, which significantly affects the course of this dynamic healthcare industry. Chronic diseases, which include cancer, cardiovascular disorders, and renal failure, are distinguished by their enduring nature and the ongoing requirement for medical interventions. With the increasing global prevalence of these health challenges, there is a corresponding exponential rise in the demand for central venous catheters (CVCs), which establishes them as essential instruments in the modern healthcare environment.
The increase in chronic diseases is attributable to several factors, including changes in lifestyle, an aging population, and the transition in global epidemiology. Sedentary behaviors and inadequate dietary practices are prime examples of unhealthy lifestyle choices that significantly contribute to the increase in chronic diseases. Furthermore, in developed countries, the aging population significantly contributes to the rise in the prevalence of illnesses that require extended medical interventions.
The probability of developing chronic diseases increases with the progression of human life, thereby augmenting the need for sophisticated medical technologies such as central venous catheters. Chronic diseases frequently necessitate extensive and prolonged treatment regimens, which produces an ongoing demand for central venous catheters to perform intravenous access, administer fluids, and deliver medications—responsibilities in which they excel.
Growing Apprehension Regarding Healthcare-associated Infections
Despite the substantial expansion of the worldwide central venous catheter market, there is a constraining factor that merits consideration: the growing apprehension and examination regarding healthcare-associated infections (HAIs). Despite playing an essential role in medical interventions, central venous catheters (CVCs) are linked to an increased risk of infections, which presents a substantial obstacle to their market growth.
Bloodstream infections (HAIs), specifically those associated with catheter use, have emerged as a significant concern for regulatory bodies, policymakers, and healthcare providers. During catheter insertion and maintenance, strict adherence to antiseptic procedures and infection control protocols is necessary due to the inherent risk of infection.
Disposal of Medical Waste
One notable obstacle that the global market for central venous catheters must contend with is the growing apprehension surrounding the ecological consequences linked to the disposal of medical waste, which includes catheters. The proliferation of single-use disposable catheters in the medical sector contributes to the escalating quantity of waste produced by healthcare facilities, thereby giving rise to environmental concerns and prompting inquiries regarding sustainability.
The disposal of central venous catheters (CVCs) after a solitary application frequently results in a considerable buildup of plastic and additional substances in landfills. Disposable catheters have an environmental impact encompassing all stages, including production, transportation, and disposal, which results in resource depletion and pollution.
Constant Progress in Catheter Technology
The constant progress in catheter technology is a favorable factor influencing the course of the worldwide central venous catheter market. This ushers in a novel era of innovation that improves healthcare efficiency and patient outcomes. The constant advancement of central venous catheter (CVC) materials, designs, and functionalities has facilitated the development of enhanced safety, user-friendliness, and a broader range of applications, establishing CVCs as indispensable instruments in modern medical practices.
Advancements in catheter design technology have led to the creation of catheters equipped with improved characteristics, including antimicrobial coatings, which effectively mitigate the potential for infections linked to catheter usage. These advancements not only enhance patient safety but also improve the efficiency of healthcare provision by reducing the financial strain linked to catheter-associated infections.
Furthermore, the incorporation of intelligent technologies, such as monitoring devices and sensors integrated into catheters, enables the accumulation of data in real-time and the remote monitoring of patients. This not only enables proactive healthcare interventions but also corresponds with the expanding phenomenon of digital health, which entails the conversion of conventional catheters into advanced devices that can offer significant insights into the health of patients.
A convergence of factors influencing the medical interventions and healthcare delivery landscape positions the global central venous catheter market for substantial expansion. Market growth for central venous catheters is substantially propelled by the rising incidence of chronic diseases, including cancer, cardiovascular disorders, and renal failure. These conditions frequently require extended medical interventions, which results in an increased need for catheters. Continuous progressions in catheter technology, such as the integration of antimicrobial coatings, intelligent monitoring functionalities, and enhanced materials, augment the central venous catheters' safety, effectiveness, and adaptability. This measure not only attends to concerns regarding patient safety but is also in line with the dynamic nature of contemporary healthcare.
An increase in the incidence of diseases necessitating sophisticated medical interventions is observed as the global population ages. Due to their capacity to deliver accurate and continuous intravenous access, central venous catheters are essential instruments in the management of healthcare requirements for the geriatric population. Enhancements in healthcare infrastructure, specifically in developing nations, play a significant role in expanding the availability of cutting-edge medical remedies. Consequently, this increases the need for central venous catheters in a multitude of medical environments. A focal point of the relationship between manufacturers and consumers in the market for central venous catheters is safety, quality, and innovation.
Manufacturers are allocating resources towards research and development endeavors to produce catheters that possess improved characteristics, thereby securing patients' safety and assuring the efficacy of medical interventions. The partnership between healthcare providers and manufacturers is of the utmost importance, given that the latter depends on the former to provide innovative solutions that address the ever-changing demands of patient care. The market for central venous catheters appears to have a bright future, as market dynamics are anticipated to be driven by ongoing innovations.
Further incorporation of digital health technologies, including data analytics and remote monitoring, into catheter designs is among the anticipated developments. This progression corresponds with the overarching pattern of healthcare that is individualized and patient focused.
Prominent participants in the market for central venous catheters consist of BD subsidiaries, Becton, Dickinson and Company, Teleflex Incorporated, and C.R. Bard, all of which are major healthcare organizations. These corporations demonstrate a robust international footprint, as evidenced by the extensive utilization of central venous catheters in influential nations such as the United States, Germany, and Japan.
The US, owing to its sophisticated healthcare infrastructure, maintains a leading position in market utilization as it extensively implements central venous catheters in hospitals and ambulatory surgical centers. Germany, a country recognized for its state-of-the-art medical technology, heavily relies on these catheters to execute sophisticated medical procedures. Japan, due to its aging population, observes the substantial implementation of chronic disease management strategies.
Prominent industry participants are proactively transforming the central venous catheter sector using ongoing innovation, strategic acquisitions, and an unwavering commitment to research and development. As an example, Becton, Dickinson, and Company is a market leader due to its emphasis on technological advancements and diverse product portfolio, which guarantee the safety and efficacy of its catheter offerings.
By leveraging strategic partnerships and improving its products, Teleflex Incorporated is augmenting its market presence. By utilizing the worldwide network of its parent company, BD enables C.R. Bard to fortify its standing. These industry leaders significantly influence the market through the implementation of innovative functionalities, guarantee adherence to regulatory standards, and address the changing demands of healthcare providers worldwide.
Which Product Category Spearheads?
CVC Catheters Find the Most Extensive Adoption
The segment about central venous catheters is anticipated to hold the most significant market share. Central venous catheters (CVCs), encompassing both tunneled and non-tunneled iterations, are extensively employed in diverse medical environments due to their adaptability and utility in administering intravenous therapies, overseeing blood parameters, and facilitating prolonged access. The extensive range of potential uses and the pivotal function that CVC catheters fulfill in various medical procedures contribute to their market dominance. The segment of central venous catheters utilized for peritoneal dialysis is anticipated to expand at the quickest rate. The escalating incidence of chronic renal diseases on a global scale has led to a growing need for peritoneal dialysis as a viable therapeutic alternative. Peritoneal dialysis catheters are essential elements of this therapeutic methodology as they enable the exchange of fluids within the abdominal cavity.
Which is the Leading Segment by Property?
Non-Antimicrobial Catheters to Sell Rapidly Owing to their Versatility
It is anticipated that the non-antimicrobial catheter segment will hold the most significant market share in the central venous catheter industry. The versatility with which non-antimicrobial catheters can provide intravenous access in a variety of healthcare settings contributes to their extensive use in medical applications. The established safety record and cost-effectiveness of non-antimicrobial catheters are additional factors that contribute to their market dominance.
On the contrary, it is expected that the anti-microbial catheter sector will experience the most rapid expansion. The demand for catheters featuring integrated antimicrobial properties is growing in healthcare settings, where infection prevention and control are becoming increasingly important. The anti-microbial catheter segment is an essential and rapidly evolving component of the central venous catheter market due to the increasing awareness of healthcare-associated infections and the demand for advanced technologies that reduce infection risks.
Which is the Most Sought-after Catheter Design?
Double Lumen Catheters to be Most Viable owing to their Ability of Concurrent Fluid Infusion
The greatest market share is anticipated to be held by the double lumen segment of the central venous catheter market. Double-lumen catheters provide the benefit of concurrent fluid infusion and withdrawal, rendering them exceedingly adaptable for a wide range of medical procedures, including hemodialysis and apheresis. The fact that they are utilized in a vast array of clinical contexts contributes to their market dominance.
In contrast, the multiple lumens market segment is anticipated to expand the most rapidly. The increasing demand for catheters featuring multiple lumens can be attributed to their capacity to enable intricate medical procedures and interventions that necessitate the concurrent administration of numerous fluids or medications. Due to their adaptability, multiple lumen catheters are at the vanguard of medical developments, which propels their exponential expansion in the market for central venous catheters.
Who are the Top End Users in the Global Market?
Hospitals to be the Dominant Force While ASCs Emerge Lucrative
It is anticipated that hospitals will hold the greatest market share in the market for central venous catheters. Hospitals function as primary centers for a diverse range of medical procedures and treatments, encompassing critical care, long-term therapies, and surgical interventions, all of which make extensive use of central venous catheters. The considerable number of patients and wide range of medical services provided by hospitals are factors that contribute to the market dominance of this particular segment.
On the contrary, the ambulatory surgical centers (ASCs) sector is anticipated to experience the most rapid expansion. The increasing preference for minimally invasive procedures and the transition toward outpatient care are the primary factors influencing the demand for central venous catheters in ambulatory surgical centers. As they provide a variety of medical services with portability, cost-effectiveness, and efficacy, ASCs are significant factors in the accelerated growth of central venous catheter usage in this market segment.
Swelling Chronic Disease Burden Uplifts Asia Pacific’s Leadership Position
The Asis Pacific region is anticipated to account for the largest market share of the worldwide central venous catheter industry. Numerous elements contribute to this state of dominance. To begin with, the Asia Pacific region is characterized by an extensive and swiftly expanding population, which has resulted in a heightened incidence of chronic ailments necessitating medical interventions such as central venous catheterization. The increasing prevalence of ailments such as cancer, cardiovascular diseases, and renal disorders in Asia Pacific nations drives the demand for these catheters.
Furthermore, the expanding availability of advanced medical remedies and the development of healthcare infrastructure in nations such as China, and India are substantial factors driving the expansion of the central venous catheter market. The rapid expansion and investment in healthcare systems in the region are expected to contribute to a greater prevalence of central venous catheters being utilized for a wide range of therapeutic purposes.
Growing Consciousness for Central Catheters in Healthcare Establishments to Provide Groundwork for Growth in the MEA
It is expected that the Middle East, and Africa will witness the most rapid expansion of the worldwide central venous catheter market. Multiple factors contribute to the expansion of this region. To begin with, a growing consciousness regarding sophisticated medical procedures and remedies has resulted in an elevated need for central venous catheters in healthcare establishments throughout the Middle East, and Africa.
The anticipated increase in these regions' economic progress and healthcare infrastructure enhancements will likely lead to a greater prevalence of contemporary medical technologies, such as central venous catheters. Furthermore, there is an increasing incidence of chronic ailments, including cardiovascular disorders and diabetes, in the Middle East, and Africa. The frequent utilization of central venous catheters for the treatment of these conditions contributes to the expansion of the market.
C.R. Bard (a subsidiary of BD), Becton, Dickinson and Company, and Teleflex Incorporated are significant market participants that influence the central venous catheter industry. These corporations utilize a variety of approaches to maintain and increase their market presence. Prominent entities place a high value on ongoing technological advancements in catheters to satisfy the changing demands of healthcare practitioners and patients. For example, Becton, Dickinson, and Company make substantial investments in research and development to introduce catheters that incorporate sophisticated attributes such as intelligent monitoring capabilities and antimicrobial coatings. Their dedication to innovation serves to improve the safety and effectiveness of their products, thereby establishing them as frontrunners in the industry.
As part of BD, corporations such as C.R. Bard engage in strategic acquisitions to expand their product lines and market presence. These entities enhance the diversity of their portfolios by acquiring complementary businesses, thereby guaranteeing their ability to service an extensive array of medicinal applications. By implementing this strategic expansion, the organization not only strengthens its market position but also empowers healthcare providers worldwide to access all-encompassing solutions.
Ensuring optimal market share necessitates a steadfast dedication to upholding superior quality standards and stringent compliance with regulatory requirements. Other industry leaders, including Becton, Dickinson, and Company, invest heavily in quality assurance programs to guarantee that their catheters meet or surpass regulatory standards. By this commitment to adherence, these organizations not only foster trust among healthcare providers but also solidify their position as frontrunners in terms of product dependability and security.
Shockwave Medical introduced the Shockwave M5+ peripheral intravascular lithotripsy catheter in March 2022, after obtaining approval from the United States Food and Drug Administration (FDA) and the CE mark.
Market Impact: Shockwave Medical's March 2022 launch of the Shockwave M5+ peripheral intravascular lithotripsy catheter, which received CE mark and Food and Drug Administration (FDA) approvals, represents a substantial development in vascular intervention technology. It is anticipated that this advancement will benefit the worldwide market by providing healthcare practitioners with a novel instrument to manage peripheral vascular diseases. This, in turn, may lead to improved treatment alternatives and potentially influence the wider acceptance of sophisticated catheter technologies in vascular interventions.
(Source: Shockwave Medical)
Cerenovus, a subsidiary of Johnson & Johnson Medical Devices Companies, introduced Emboguard, an advanced balloon guide catheter designed for endovascular procedures, including those involving patients experiencing acute ischemic stroke, in February 2022.
Market Impact: Particularly for patients with transient ischemic stroke, the February 2022 introduction of Emboguard by Cerenovus, a subsidiary of Johnson & Johnson Medical Devices Companies, represents a significant advancement in endovascular procedures. It is anticipated that this advancement will have a beneficial effect on the international market by providing a cutting-edge solution that improves the effectiveness and safety of catheter-based interventions for acute ischemic stroke. As a result, it may influence the accepted norm and stimulate the global implementation of sophisticated catheter technologies in neurovascular procedures.
(Source: Neuro News International)
2023 to 2030
Historical Data Available for
2018 to 2022
US$ Million for Value
Key Regions Covered
Key Countries Covered
Key Market Segments Covered
Key Companies Profiled
Customization & Pricing
Available upon request
By End User:
The market is anticipated to grow at a CAGR of 5.0% during the projected period.
The central venous catheter market was valued at US$3.2 billion in 2023.
The US held the largest market share in 2023
Some of the prominent players in the market are Angio Dynamics, C.R. Bard, Teleflex Incorporated, B. Braun Melsungen AG, and Kimal Healthcare.
The ambulatory surgical centers segment is expected to grow at the fastest growth during the forecast period.